117 related articles for article (PubMed ID: 16124004)
1. Syncoilin upregulation in muscle of patients with neuromuscular disease.
Brown SC; Torelli S; Ugo I; De Biasia F; Howman EV; Poon E; Britton J; Davies KE; Muntoni F
Muscle Nerve; 2005 Dec; 32(6):715-25. PubMed ID: 16124004
[TBL] [Abstract][Full Text] [Related]
2. Muscular dystrophies related to the cytoskeleton/nuclear envelope.
Nowak K; McCullagh K; Poon E; Davies KE
Novartis Found Symp; 2005; 264():98-111; discussion 112-7, 227-30. PubMed ID: 15773750
[TBL] [Abstract][Full Text] [Related]
3. Dysbindin, syncoilin, and beta-synemin mRNA levels in dystrophic muscles.
Wakayama Y; Matsuzaki Y; Yamashita S; Inoue M; Jimi T; Hara H; Unaki A; Iijima S; Masaki H
Int J Neurosci; 2010 Feb; 120(2):144-9. PubMed ID: 20199207
[TBL] [Abstract][Full Text] [Related]
4. Association of syncoilin and desmin: linking intermediate filament proteins to the dystrophin-associated protein complex.
Poon E; Howman EV; Newey SE; Davies KE
J Biol Chem; 2002 Feb; 277(5):3433-9. PubMed ID: 11694502
[TBL] [Abstract][Full Text] [Related]
5. Syncoilin, an intermediate filament-like protein linked to the dystrophin associated protein complex in skeletal muscle.
Moorwood C
Cell Mol Life Sci; 2008 Oct; 65(19):2957-63. PubMed ID: 18810324
[TBL] [Abstract][Full Text] [Related]
6. Plasma membrane cytoskeleton of muscle: a fine structural analysis.
Watkins SC; Cullen MJ; Hoffman EP; Billington L
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):131-41. PubMed ID: 10679961
[TBL] [Abstract][Full Text] [Related]
7. Desmuslin, an intermediate filament protein that interacts with alpha -dystrobrevin and desmin.
Mizuno Y; Thompson TG; Guyon JR; Lidov HG; Brosius M; Imamura M; Ozawa E; Watkins SC; Kunkel LM
Proc Natl Acad Sci U S A; 2001 May; 98(11):6156-61. PubMed ID: 11353857
[TBL] [Abstract][Full Text] [Related]
8. Syncoilin, a novel member of the intermediate filament superfamily that interacts with alpha-dystrobrevin in skeletal muscle.
Newey SE; Howman EV; Ponting CP; Benson MA; Nawrotzki R; Loh NY; Davies KE; Blake DJ
J Biol Chem; 2001 Mar; 276(9):6645-55. PubMed ID: 11053421
[TBL] [Abstract][Full Text] [Related]
9. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
[TBL] [Abstract][Full Text] [Related]
10. Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in alpha-dystroglycanopathies.
Taniguchi M; Kurahashi H; Noguchi S; Fukudome T; Okinaga T; Tsukahara T; Tajima Y; Ozono K; Nishino I; Nonaka I; Toda T
Hum Mol Genet; 2006 Apr; 15(8):1279-89. PubMed ID: 16531417
[TBL] [Abstract][Full Text] [Related]
11. The up-regulation of utrophin is not limited to muscular dystrophies.
Lukás Z
Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():87-9. PubMed ID: 10707847
[TBL] [Abstract][Full Text] [Related]
12. Sub-cellular localisation of fukutin related protein in different cell lines and in the muscle of patients with MDC1C and LGMD2I.
Torelli S; Brown SC; Brockington M; Dolatshad NF; Jimenez C; Skordis L; Feng LH; Merlini L; Jones DH; Romero N; Wewer U; Voit T; Sewry CA; Noguchi S; Nishino I; Muntoni F
Neuromuscul Disord; 2005 Dec; 15(12):836-43. PubMed ID: 16288869
[TBL] [Abstract][Full Text] [Related]
13. Intermediate filament-like protein syncoilin in normal and myopathic striated muscle.
McCullagh KJ; Edwards B; Poon E; Lovering RM; Paulin D; Davies KE
Neuromuscul Disord; 2007 Dec; 17(11-12):970-9. PubMed ID: 17629480
[TBL] [Abstract][Full Text] [Related]
14. Different pattern of HSP47 expression in skeletal muscle of patients with neuromuscular diseases.
Higuchi I; Hashiguchi A; Matsuura E; Higashi K; Shiraishi T; Hirata N; Arimura K; Osame M
Neuromuscul Disord; 2007 Mar; 17(3):221-6. PubMed ID: 17324572
[TBL] [Abstract][Full Text] [Related]
15. Muscular dystrophies, the cytoskeleton and cell adhesion.
Spence HJ; Chen YJ; Winder SJ
Bioessays; 2002 Jun; 24(6):542-52. PubMed ID: 12111737
[TBL] [Abstract][Full Text] [Related]
16. Desmin-related neuromuscular disorders.
Goebel HH
Muscle Nerve; 1995 Nov; 18(11):1306-20. PubMed ID: 7565929
[TBL] [Abstract][Full Text] [Related]
17. Syncoilin accumulation in two patients with desmin-related myopathy.
Howman EV; Sullivan N; Poon EP; Britton JE; Hilton-Jones D; Davies KE
Neuromuscul Disord; 2003 Jan; 13(1):42-8. PubMed ID: 12467731
[TBL] [Abstract][Full Text] [Related]
18. Muscle progenitor cell proliferation during passive stretch of unweighted soleus in dystrophin deficient mice.
Turtikova OV; Altaeva EG; Tarakina MV; Malashenko AM; Nemirovskaya TL; Shenkman BS
J Gravit Physiol; 2007 Jul; 14(1):P95-6. PubMed ID: 18372716
[TBL] [Abstract][Full Text] [Related]
19. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
Au CG; Butler TL; Egan JR; Cooper ST; Lo HP; Compton AG; North KN; Winlaw DS
Acta Neuropathol; 2008 Sep; 116(3):235-46. PubMed ID: 18392839
[TBL] [Abstract][Full Text] [Related]
20. Pattern of metalloprotease activity and myofiber regeneration in skeletal muscles of mdx mice.
Bani C; Lagrota-Candido J; Pinheiro DF; Leite PE; Salimena MC; Henriques-Pons A; Quirico-Santos T
Muscle Nerve; 2008 May; 37(5):583-92. PubMed ID: 18288709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
